Intellistem develops innovative cellular immune cancer treatments.
Intellistem has raised $1.2M in total funding. The most recent round was Seed. The last funding was announced in April 2024.
Intellistem is headquartered in San Francisco, United States.
Intellistem develops innovative cellular immune cancer treatments.
Intellistem is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Intellistem — Funding & Investors." VCBacked, April 16, 2024, https://www.vcbacked.co/company/intellistem. Accessed August 24, 2026.
VCBacked. (2024). Intellistem — Funding & Investors. Retrieved August 24, 2026, from https://www.vcbacked.co/company/intellistem
{{cite web |title=Intellistem — Funding & Investors |url=https://www.vcbacked.co/company/intellistem |website=VCBacked |access-date=August 24, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated